48 related articles for article (PubMed ID: 8904106)
1. In vitro activity of sparfloxacin against selected enterobacteriaceae and pseudomonaceae including Ps. pseudomallei (melioidosis).
Siristonpun Y; Rojnapisarnvong V; Srimuang S; Tanphaichitra D
J Chemother; 1995 Nov; 7 Suppl 4():54-5. PubMed ID: 8904106
[No Abstract] [Full Text] [Related]
2. In vitro activity of tosufloxacin against Pseudomonas pseudomallei, Salmonella spp. and other Enterobacteriaceae.
Srimuang S; Fugpholngam V; Asvanich K; Chongchitmate A; Tanphaichitra D
Drugs; 1995; 49 Suppl 2():260. PubMed ID: 8549324
[No Abstract] [Full Text] [Related]
3. In vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, and Enterobacteriaceae.
Rossolini GM; Valentini S; Vaiani G; Satta G
J Chemother; 1989 Jul; 1(4 Suppl):173-6. PubMed ID: 16312356
[No Abstract] [Full Text] [Related]
4. Activity of five fluoroquinolones against 71 isolates of Burkholderia pseudomallei.
Ho PL; Cheung TK; Kinoshita R; Tse CW; Yuen KY; Chau PY
J Antimicrob Chemother; 2002 Jun; 49(6):1042-4. PubMed ID: 12039903
[No Abstract] [Full Text] [Related]
5. [Bactericidal activity of quinolones (including sparfloxacin) against Enterococcus; in vitro antagonisms with gentamicin].
Watine J; Charet JC
Pathol Biol (Paris); 1997 May; 45(5):430-2. PubMed ID: 9296098
[TBL] [Abstract][Full Text] [Related]
6. [In vitro activity of sparfloxacin against methicillin-resistant staphylococci].
Wallrauch C; Voss A; Milatovic D; Braveny I
Arzneimittelforschung; 1995 Jun; 45(6):723-5. PubMed ID: 7646580
[TBL] [Abstract][Full Text] [Related]
7. Microbiological studies on lomefloxacin--a new quinolone.
Newsom SW; Rowland C
J Chemother; 1989 Jul; 1(4 Suppl):168-9. PubMed ID: 16312354
[No Abstract] [Full Text] [Related]
8. In-vitro activity of OPC-17116 against bacterial enteric pathogens.
Arduino RC; Frosolono M; Murray BE
J Antimicrob Chemother; 1994 Sep; 34(3):403-7. PubMed ID: 7829414
[No Abstract] [Full Text] [Related]
9. [In vitro antibacterial activity of a new fluoroquinolone, sparfloxacin, against nosocomial bacteria, and concordance curve].
Soussy CJ; Cluzel M; Derlot E; Exmelin L; Kitzis MD; Dabernat H; Le Noc P; Muller-Serieys C; Reverdy ME; Scheftel JM; Thabaut A
Pathol Biol (Paris); 1996 Apr; 44(4):241-8. PubMed ID: 8763585
[TBL] [Abstract][Full Text] [Related]
10. Comparative activity of three new fluoroquinolones.
Coll R; Esteve M; Moros M; Parés J; Xicota MA
Chemioterapia; 1987 Jun; 6(2 Suppl):152-3. PubMed ID: 3509374
[No Abstract] [Full Text] [Related]
11. Sparfloxacin and other new fluoroquinolones.
Richard P; Gutmann L
J Antimicrob Chemother; 1992 Dec; 30(6):739-44. PubMed ID: 1337749
[No Abstract] [Full Text] [Related]
12. Activity of sparfloxacin against Mycobacterium leprae measured by the proportional bactericidal test.
McDermott-Lancaster RD; Banerjee DK
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):605-8. PubMed ID: 8151193
[TBL] [Abstract][Full Text] [Related]
13. Melioidosis: when in doubt leave the quinolone alone!
Ashdown LR; Currie BJ
Med J Aust; 1992 Sep; 157(6):427-8. PubMed ID: 1280318
[No Abstract] [Full Text] [Related]
14. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
Mirelis B; Navarro F; Miró E; Coll R; Xicota MA; Prats G
Drugs Exp Clin Res; 1995; 21(4):129-38. PubMed ID: 8529525
[TBL] [Abstract][Full Text] [Related]
15. Breakpoint determination: rufloxacin.
Eur J Clin Microbiol Infect Dis; 1993 Jul; 12(7):574-5. PubMed ID: 8404928
[No Abstract] [Full Text] [Related]
16. In vitro activity of sitafloxacin against Burkholderia pseudomallei.
Thamlikitkul V; Trakulsomboon S
Int J Antimicrob Agents; 2011 Oct; 38(4):364. PubMed ID: 21775108
[No Abstract] [Full Text] [Related]
17. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
Ismaeel NA; Tayeb OS
Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
[TBL] [Abstract][Full Text] [Related]
18. Comparative in-vitro activity of rufloxacin with five other antimicrobial agents against bacterial enteric pathogens.
Soriano F; Fernández-Roblas R; López JC; García-Corbeira P; Aguilar L
J Antimicrob Chemother; 1994 Jul; 34(1):157-60. PubMed ID: 7961202
[No Abstract] [Full Text] [Related]
19. In vitro activity of sparfloxacin against selected gram-negative blood culture isolates.
Siristonpun Y; Rojnpisarnvong V; Chongchitmate A; Srimuang S; Tanphaichitra D
Drugs; 1995; 49 Suppl 2():256. PubMed ID: 8549322
[No Abstract] [Full Text] [Related]
20. In vitro activities of the newer quinolones garenoxacin, gatifloxacin, and gemifloxacin against human mycoplasmas.
Pereyre S; Renaudin H; Bébéar C; Bébéar CM
Antimicrob Agents Chemother; 2004 Aug; 48(8):3165-8. PubMed ID: 15273141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
